We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Patient capital

26 February 2020 By Anna Szymanski

They’re supposed to harness market power to help in a health crisis. Yet pandemic bonds are ill-suited to the task. Complex restrictions and the need to lure buyers mean creditors tend to get the upper hand – and recipients of the funds may benefit little even if they win.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)